Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Other Operating Expenses (2022 - 2024)

Dianthus Therapeutics (DNTH) has 5 years of Other Operating Expenses data on record, last reported at -$4.8 million in Q4 2024.

  • For Q4 2024, Other Operating Expenses changed N/A year-over-year to -$4.8 million; the TTM value through Sep 2025 reached -$4.8 million, changed N/A, while the annual FY2024 figure was -$4.8 million, N/A changed from the prior year.
  • Other Operating Expenses reached -$4.8 million in Q4 2024 per DNTH's latest filing, down from -$1.9 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $15.1 million in Q4 2022 and bottomed at -$18.0 million in Q1 2023.
  • Average Other Operating Expenses over 3 years is -$2.4 million, with a median of -$3.4 million recorded in 2023.